| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |